MPM Asset Management

Latest statistics and disclosures from Mpm Asset Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are DYN, TRDA, ITOS, HOWL, RPTX, and represent 96.42% of Mpm Asset Management's stock portfolio.
  • Reduced shares in these 3 stocks: DYN (-$43M), Harpoon Therapeutics, ADAP.
  • Sold out of its position in Harpoon Therapeutics.
  • Mpm Asset Management was a net seller of stock by $-45M.
  • Mpm Asset Management has $245M in assets under management (AUM), dropping by 31.31%.
  • Central Index Key (CIK): 0001263048

Tip: Access up to 7 years of quarterly data

Positions held by MPM Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Mpm Asset Management

Mpm Asset Management holds 6 positions in its portfolio as reported in the March 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Dyne Therapeutics Common (DYN) 40.0 $98M -30% 3.5M 28.39
 View chart
Entrada Therapeutics Common (TRDA) 25.6 $63M 4.4M 14.17
 View chart
iTeos Therapeutics Common (ITOS) 15.2 $37M 2.7M 13.64
 View chart
Werewolf Therapeutics Common (HOWL) 11.3 $28M 4.3M 6.48
 View chart
Repare Therapeutics Common (RPTX) 4.3 $11M 2.2M 4.71
 View chart
Adaptimmune Therapeutics Sponsored ADR (ADAP) 3.6 $8.8M -11% 5.6M 1.58
 View chart

Past Filings by Mpm Asset Management

SEC 13F filings are viewable for Mpm Asset Management going back to 2011

View all past filings